The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...

Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

The intricate division of labor within a "crown-shaped" protein complex, which viruses use to replicate their ribonucleic ...

Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.

At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...

The FDA has granted fast track and rolling review status to Celltrion’s CT-P71, a Nectin-4 targeting ADC for treating ...

Scientists have discovered that a protein linked to cell death is secretly driving the aging of blood stem cells in a ...

Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion ...

The development targets sepsis, a condition responsible for millions of deaths each year worldwide. Scientists from CIBER at ...